ArticleJournal of managed care & specialty pharmacy2023

Short-term cost-effectiveness analysis of tirzepatide for the treatment of type 2 diabetes in the United States.

Xiaotong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.